Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2020 Aug 6;8(3):443.
doi: 10.3390/vaccines8030443.

Investigating Virological, Immunological, and Pathological Avenues to Identify Potential Targets for Developing COVID-19 Treatment and Prevention Strategies

Affiliations
Review

Investigating Virological, Immunological, and Pathological Avenues to Identify Potential Targets for Developing COVID-19 Treatment and Prevention Strategies

Zafar Mahmood et al. Vaccines (Basel). .

Abstract

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is an emerging coronavirus causing respiratory disease commonly known as COVID-19. This novel coronavirus transmits from human to human and has caused profound morbidity and mortality worldwide leading to the ongoing pandemic. Moreover, disease severity differs considerably from individual to individual. Investigating the virology of COVID-19 and immunological pathways underlying its clinical manifestations will enable the identification and design of effective vaccines and potential therapies. In this review, we explore COVID-19 virology, the contribution of the immune system (innate and adaptive) during infection and control of the virus. Finally, we highlight vaccine development and implications of immune system modulation for potential therapeutic interventions to design better therapeutic strategies to guide future cure.

Keywords: B cells; COVID-19; T cells; vaccine development.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflict of interest.

Figures

Figure 1
Figure 1
Coronavirus structure showing the organization of spike (S), membrane (M), and envelope (E) proteins. The viral RNA is associated with the nucleocapsid protein (N). ACE: angiotensin converting enzyme; RBD: receptor-binding domains; S1-NTD: N-terminal domain; S1-CTD: C-terminal domain; S1: amino termini; S2: carboxy termini.
Figure 2
Figure 2
Genomic organization of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), including open reading frames (ORF1a and ORF1b), spike (S), envelope (E), membrane (M), and nucleocapsid (N) proteins. Three-dimensional protein structures of 3CL-protease, endoribonuclease and spike protein bound to the human angiotensin converting enzyme 2 (ACE2) receptor are illustrated. PDB: Protein database.
Figure 3
Figure 3
SARS-CoV-2 replication cycle and potential therapeutic targets.
Figure 4
Figure 4
Immune dysregulation mechanisms during coronavirus disease 2019 (COVID-19).
Figure 5
Figure 5
Clinical phase vaccine candidates for COVID-19.

References

    1. Amanat F., Krammer F. SARS-CoV-2 Vaccines: Status Report. Immunity. 2020;52:583–589. doi: 10.1016/j.immuni.2020.03.007. - DOI - PMC - PubMed
    1. Petrosillo N., Viceconte G., Ergonul O., Ippolito G., Petersen E. COVID-19, SARS and MERS: Are they closely related? Clin. Microbiol. Infect. 2020;26:729–734. doi: 10.1016/j.cmi.2020.03.026. - DOI - PMC - PubMed
    1. Coleman C.M., Frieman M.B. Coronaviruses: Important emerging human pathogens. J. Virol. 2014;88:5209–5212. doi: 10.1128/JVI.03488-13. - DOI - PMC - PubMed
    1. Li W., Shi Z., Yu M., Ren W., Smith C., Epstein J.H., Wang H., Crameri G., Hu Z., Zhang H., et al. Bats Are Natural Reservoirs of SARS-Like Coronaviruses. Science. 2005;310:676–679. doi: 10.1126/science.1118391. - DOI - PubMed
    1. Zaki A.M., van Boheemen S., Bestebroer T.M., Osterhaus A.D.M.E., Fouchier R.A.M. Isolation of a Novel Coronavirus from a Man with Pneumonia in Saudi Arabia. N. Engl. J. Med. 2012;367:1814–1820. doi: 10.1056/NEJMoa1211721. - DOI - PubMed

LinkOut - more resources